Today, we launch a consultation exercise to ask health researchers and the public to submit their ideas for the most important research topics we should be considering in bowel cancer screening.
To mark our 500th PHE Screening blog post, we’re launching a survey so you can let us know how to make our next 500 posts even better than the last.
A list of every blog issued in March 2018.
The UK National Screening Committee is consulting publicly until 4 November on whether an evaluation of screening for screening for severe combined immunodeficiency (SCID) should be undertaken in the NHS.
We have launched a period of consultation on the draft NHS Sickle Cell and Thalassaemia Screening Programme handbook.
The annual call is your opportunity to make a proposal for a new topic to be considered by the UK NSC as part of its regular review process.
I’m delighted to report that following the sterling work of our child vision group, we are now consulting on all the draft resources they have produced.
Are you involved in antenatal sickle cell and thalassaemia (SCT) screening? Do you counsel women and couples at risk of having a baby with a significant haemoglobin disorder? Are you aware of all the resources available to support your counselling?
In 1988, the UK implemented the first national breast screening programme following evidence published in the Forrest Report.
If you’ve contacted the PHE Screening helpdesk recently, you may have noticed and even completed, our latest user survey.